Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/44410, first published .
Development and Validation of a Respiratory-Responsive Vocal Biomarker–Based Tool for Generalizable Detection of Respiratory Impairment: Independent Case-Control Studies in Multiple Respiratory Conditions Including Asthma, Chronic Obstructive Pulmonary Disease, and COVID-19

Development and Validation of a Respiratory-Responsive Vocal Biomarker–Based Tool for Generalizable Detection of Respiratory Impairment: Independent Case-Control Studies in Multiple Respiratory Conditions Including Asthma, Chronic Obstructive Pulmonary Disease, and COVID-19

Development and Validation of a Respiratory-Responsive Vocal Biomarker–Based Tool for Generalizable Detection of Respiratory Impairment: Independent Case-Control Studies in Multiple Respiratory Conditions Including Asthma, Chronic Obstructive Pulmonary Disease, and COVID-19

Savneet Kaur   1 * , MBBS ;   Erik Larsen   2 * , PhD ;   James Harper   2 , PhD ;   Bharat Purandare   3 , MBBS, MD ;   Ahmet Uluer   4 , DO, MPH ;   Mohammad Adrian Hasdianda   4 , MD, MSc, MMSc ;   Nikita Arun Umale   4 , MBBS, MPH ;   James Killeen   5 , MD ;   Edward Castillo   5 , PhD, MPH ;   Sunit Jariwala   1 , MD

1 Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States

2 Sonde Health, Boston, MA, United States

3 Deenanath Mangeshkar Hospital, Pune, India

4 Brigham and Women's Hospital, Boston, MA, United States

5 University of California, San Diego, CA, United States

*these authors contributed equally

Corresponding Author: